featured
Toward Personalized Dosing of B-Cell–Depleting Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neuroimmunology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels after B cell depletion with Ocrelizumab
J. Neuroimmunol. 2024 Dec 02;399(xx)578502, CJ Gurski, Z Hajiyeva, AJ Veltri, K Fenton, S O'Dell, AZ Obeidat, BN DittelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.